Publications

From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxis.

Authors: O Yogev, O Weissbrod, G Battistoni, D Bressan, A Naamati, I Falciatori, AC ...

E-pub date: 16 Mar 2023

Journal name: Commun Biol

A large-scale retrospective study in metastatic breast cancer patients using circulating tumor DNA and machine learning to predict treatment outcome and progression-free survival

Authors: EJ Beddowes, M Ortega-Duran, S Karapanagiotis, A Martin, M Gao, R Masina, R...

E-pub date: 3 Mar 2023

Journal name:

Preclinical PET Imaging of Tumor Cell Death following Therapy Using Gallium-68-Labeled C2Am.

Authors: F Bulat, F Hesse, B Attili, C Solanki, IA Mendichovszky, F Aigbirhio, FJ Le...

E-pub date: 2 Mar 2023

Journal name: Cancers (Basel)

p53 in senescence – it’s a marathon, not a sprint.

Authors: E Sheekey, M Narita

E-pub date: 1 Mar 2023

Journal name: FEBS J

Cellular senescence: beneficial, harmful, and highly complex.

Authors: DJ Baker, M Narita, P Muñoz-Cánoves

E-pub date: 1 Mar 2023

Journal name: FEBS J

High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.

Authors: J van Dorp, C Pipinikas, BBM Suelmann, N Mehra, N van Dijk, G Marsico, ML v...

E-pub date: 1 Mar 2023

Journal name: Nat Med

CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.

Authors: E-Y Kang, A Weir, NS Meagher, K Farrington, GS Nelson, P Ghatage, C-H Lee, ...

E-pub date: 1 Mar 2023

Journal name: Cancer

Single-copy Snail upregulation causes partial epithelial-mesenchymal transition in colon cancer cells.

Authors: F Junaid, G Tomic, R Kemp, DJ Winton

E-pub date: 14 Feb 2023

Journal name: BMC Cancer

Filters

Research Groups

Core Facilities

Start date

End date

From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxis.

A large-scale retrospective study in metastatic breast cancer patients using circulating tumor DNA and machine learning to predict treatment outcome and progression-free survival

Preclinical PET Imaging of Tumor Cell Death following Therapy Using Gallium-68-Labeled C2Am.

p53 in senescence – it’s a marathon, not a sprint.

Cellular senescence: beneficial, harmful, and highly complex.

High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.

CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.

Single-copy Snail upregulation causes partial epithelial-mesenchymal transition in colon cancer cells.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxis.

A large-scale retrospective study in metastatic breast cancer patients using circulating tumor DNA and machine learning to predict treatment outcome and progression-free survival

Preclinical PET Imaging of Tumor Cell Death following Therapy Using Gallium-68-Labeled C2Am.

p53 in senescence – it’s a marathon, not a sprint.

Cellular senescence: beneficial, harmful, and highly complex.

High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.

CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.

Single-copy Snail upregulation causes partial epithelial-mesenchymal transition in colon cancer cells.